Fate Therapeutics, Inc. · NASDAQ:FATE

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc. (Schedule 13D/A)

Event Jul 2, 2025 · Filed Jul 3, 2025

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc., 17,941,579 shares, with active intent on Jul 2, 2025. Filed Jul 3, 2025 (Schedule 13D/A).

Stake
14.90%
Shares
17,941,579
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Redmile Group, LLC14.90%17,941,579
Jeremy C. Green14.90%17,941,579
RedCo II Master Fund, L.P.11.30%13,479,013

Source

View original at SEC

Related